Evan Spiegel and Michel Vounatsos
Evan Spiegel and Michel Vounatsos

Evan Spiegel and Michel Vounatsos

Evan Spiegel and Michel Vounatsos represent two very different paths to high-profile business leadership. Spiegel became a technology entrepreneur and the co-founder and CEO of Snap Inc., while Vounatsos built a decades-long career in the pharmaceutical industry before leading Biogen. Spiegel is known worldwide for Snapchat and his technology fortune, whereas Vounatsos is recognized primarily for his senior roles at Merck and Biogen. Their ages, education, careers, wealth and publicly documented personal details show a clear contrast between Silicon Valley entrepreneurship and global pharmaceutical leadership.

Evan Spiegel and Michel Vounatsos – Quick Bio Table

Profile DetailEvan SpiegelMichel Vounatsos
Full NameEvan Thomas SpiegelMichel Vounatsos
Date of BirthJune 4, 1990Not publicly confirmed
Age (2026)36 yearsApproximately 64–65 years
BirthplaceLos Angeles, California, USANot reliably documented
NationalityAmericanFrench background; exact citizenship not clearly documented in the major sources reviewed
ProfessionEntrepreneur, technology executivePharmaceutical executive, board director
Famous ForCo-founder and CEO of Snap Inc. / SnapchatFormer CEO of Biogen and senior Merck executive
Net WorthApproximately $2.2 billion$26,625,221 in 2022
HeightApproximately 5 ft 11 in (180 cm), estimatedNot officially documented
WeightApproximately 75 kg, estimatedNot officially documented
EducationStanford UniversityC.S.C.T. in Medicine, Université Victor Segalen, Bordeaux II; MBA, HEC School of Management, Paris
Degree / QualificationB.S. in Engineering – Product DesignMedical certificate + MBA
ParentsJohn W. Spiegel and Melissa Ann ThomasNot reliably documented
SiblingsTwo younger sisters, Caroline and LaurenNot reliably documented
Marital StatusMarriedNot reliably confirmed publicly
SpouseMiranda KerrNot publicly confirmed
ChildrenThree childrenNot publicly confirmed
Career StartedTechnology/entrepreneurship during Stanford yearsPharmaceutical and management career
Major CompanySnap Inc.Biogen / Merck & Co.
Snapchat ConnectionCo-founded SnapchatNone
Biogen ConnectionNoneCEO from 2017 to 2022
Merck ConnectionNoneApproximately 20 years at Merck
Previous Major RoleCo-founder and CEO, Snap Inc.EVP & Chief Commercial Officer, Biogen
CEO RoleSnap Inc. CEO since 2012Biogen CEO, 2017–2022
Board ExperienceSnap board; previously KKR boardMultiple biotechnology/life-sciences board and advisory roles
International ExperiencePrimarily U.S./global technology marketEurope, China and United States
IndustryTechnology / Social MediaPharmaceuticals / Biotechnology / Healthcare
Known Career AchievementBuilt Snapchat into a major global social-media platformLed Biogen after two decades of pharmaceutical leadership at Merck
Youngest Billionaire AchievementBecame the world’s youngest billionaire at 24Not applicable
Hair ColorBrown / dark brownNot reliably documented
Eye ColorDark brownNot reliably documented
Hobbies / InterestsDesign, technology, exercise, meditation, yoga, cooking and family interestsNot sufficiently documented by reliable public sources
InstagramPublic social-media presence associated with Evan Spiegel; personal account details should be verified before publicationNo clearly verified personal Instagram account identified
Current CareerCEO and co-founder of Snap Inc.Life-sciences executive, board member and adviser
Current Public ProfileTechnology billionaire and Snapchat co-founderExperienced pharmaceutical and biotechnology executive
Estimated Career EarningsMulti-billion-dollar wealth largely tied to Snap ownershipFormer CEO-level compensation; no reliable lifetime earnings estimate
Public Net Worth SourceForbes: about $2.2 billion in September 2026No dependable current public estimate
Private Life AvailabilityModerately documentedLimited public information
Overall Career FieldTechnology & EntrepreneurshipPharmaceuticals & Healthcare Leadership

Evan Spiegel and Michel Vounatsos Images

Evan Spiegel and Michel Vounatsos Instagram

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *